ARCHIVES

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

‘Be Careful We’re Not Fighting Old Battles’ On Study Section Issue

September 20, 1991

FDA To Limit Radiation Doses from Medical Imaging

February 12, 2010

DeVita Asks Panel’s Assistance On Personnel Ceilings, Construction, New NCAB Appointments

December 9, 1983

AACI Committee Makes Case For Clinical Research In Centers; Cancer Control, Group Funds Eyed

December 8, 1978

Clinical Trials Approved By NCI CTEP Last Month

March 25, 2011

NCI Advisors Approve Plan For Repository For Prostate Cancer Issue Specimens

March 19, 1999